ViaCyte Q&A: CRISPR Tx quick progress, ongoing diabetes trial, & more - The Niche
Today's post is a new interview with ViaCyte leadership on recent upbeat developments including work with CRISPR and an ongoing trial enrolling again.
Professor Paul Knoepfler, Ph.D.
